Key Market Indicators
Sales of digestive system disorder medicines in the Czech Republic are projected to reach $654.4 million by 2026. This is up from $587.7 million in 2021, representing an average annual growth rate of 1.7%. Since 1995, the Czech market has grown at a yearly rate of 5.2%. In 2021, it ranked 15th globally, overtaken by Sweden, which reported sales of $587.7 million. Japan, South Korea and Canada took the second, third and fourth spots, respectively.
